Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease

by C. Meier, K. Freiburghaus, C. Bovet, J. Schniering, Y. Allanore, O. Distler, C. Nakas, B. Maurer
Published 2020-12-01

ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis

by Lukas Bütikofer, Pierre A. Varisco, O. Distler, O. Kowal-Bielecka, Y. Allanore, G. Riemekasten, P. M. Villiger, S. Adler, on behalf of EUSTAR collaborators
Published 2020-03-01

Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature

by M. R. Pokeerbux, J. Giovannelli, L. Dauchet, L. Mouthon, C. Agard, J. C. Lega, Y. Allanore, P. Jego, B. Bienvenu, S. Berthier, A. Mekinian, E. Hachulla, D. Launay
Published 2019-04-01

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey

by J. Blagojevic, S. Bellando-Randone, G. Abignano, J. Avouac, L. Cometi, L. Czirják, C. P. Denton, O. Distler, M. Frerix, S. Guiducci, D. Huscher, V. K. Jaeger, V. Lóránd, B. Maurer, S. Nihtyanova, G. Riemekasten, E. Siegert, I. H. Tarner, S. Vettori, U. A. Walker, Y. Allanore, U. Müller-Ladner, F. Del Galdo, M. Matucci-Cerinic, EUSTAR co-workers
Published 2019-01-01